PCRX vs. SGOV
PCRX (Pacira BioSciences, Inc.) is a stock, while SGOV (iShares 0-3 Month Treasury Bond ETF) is Ultrashort Bond fund tracking the ICE 0-3 Month US Treasury Securities Index. Over the past 5 years, PCRX returned -14.85%/yr vs 3.62%/yr for SGOV. At a correlation of -0.05, they often move in opposite directions.
Performance
PCRX vs. SGOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PCRX achieves a -1.55% return, which is significantly lower than SGOV's 1.90% return.
PCRX
- 1D
- -0.08%
- 1M
- 10.83%
- 6M
- 8.29%
- YTD
- -1.55%
- 1Y
- 11.27%
- 3Y*
- -12.15%
- 5Y*
- -14.85%
- 10Y*
- -3.65%
SGOV
- 1D
- 0.02%
- 1M
- 0.28%
- 6M
- 1.80%
- YTD
- 1.90%
- 1Y
- 3.86%
- 3Y*
- 4.67%
- 5Y*
- 3.62%
- 10Y*
- —
PCRX vs. SGOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | -1.55% | 37.37% | -44.16% | -12.61% | -35.83% | 0.55% | 34.02% |
SGOV iShares 0-3 Month Treasury Bond ETF | 1.90% | 4.24% | 5.27% | 5.12% | 1.58% | 0.04% | 0.04% |
Correlation
The correlation between PCRX and SGOV is -0.13, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.07 |
Correlation (All Time) Calculated using the full available price history since May 28, 2020 | -0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCRX vs. SGOV — Risk / Return Rank
PCRX
SGOV
PCRX vs. SGOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacira BioSciences, Inc. (PCRX) and iShares 0-3 Month Treasury Bond ETF (SGOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PCRX | SGOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -20.57 | ||
| Sortino ratioReturn per unit of downside risk | -385.29 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 386.06 | -384.99 |
| Calmar ratioReturn relative to maximum drawdown | 0.26 | 394.07 | -393.82 |
| Martin ratioReturn relative to average drawdown | 0.55 | 6,243.29 | -6,242.74 |
Loading charts...
Drawdowns
PCRX vs. SGOV - Drawdown Comparison
The maximum PCRX drawdown since its inception was -90.19%, which is greater than SGOV's maximum drawdown of -0.03%. Use the drawdown chart below to compare losses from any high point for PCRX and SGOV.
Loading charts...
Drawdown Indicators
| PCRX | SGOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.19% | -0.03% | -90.16% |
Max Drawdown (1Y)Largest decline over 1 year | -29.61% | -0.01% | -29.60% |
Max Drawdown (3Y)Largest decline over 3 years | -70.36% | -0.01% | -70.35% |
Max Drawdown (5Y)Largest decline over 5 years | -85.67% | -0.03% | -85.64% |
Max Drawdown (10Y)Largest decline over 10 years | -85.67% | — | — |
Current DrawdownCurrent decline from peak | -78.64% | 0.00% | -78.64% |
Average DrawdownAverage peak-to-trough decline | -50.19% | -0.00% | -50.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.76% | 0.00% | +13.76% |
Volatility
PCRX vs. SGOV - Volatility Comparison
Pacira BioSciences, Inc. (PCRX) has a higher volatility of 6.87% compared to iShares 0-3 Month Treasury Bond ETF (SGOV) at 0.05%. This indicates that PCRX's price experiences larger fluctuations and is considered to be riskier than SGOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PCRX | SGOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.87% | 0.05% | +6.82% |
Volatility (6M)Calculated over the trailing 6-month period | 27.97% | 0.13% | +27.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.02% | 0.19% | +36.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.55% | 0.24% | +45.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.65% | 0.24% | +46.41% |
Dividends
PCRX vs. SGOV - Dividend Comparison
PCRX has not paid dividends to shareholders, while SGOV's dividend yield for the trailing twelve months is around 3.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SGOV iShares 0-3 Month Treasury Bond ETF | 3.80% | 4.10% | 5.10% | 4.87% | 1.45% | 0.03% | 0.05% |
Frequently Asked Questions
PCRX and SGOV have a correlation of -0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PCRX has higher volatility (6.87%) compared to SGOV (0.05%). In terms of maximum drawdown, PCRX dropped -90.19% vs SGOV's -0.03%.
SGOV currently has the higher Sharpe Ratio (20.77 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PCRX and SGOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer